MARKET AUTHORIZATION APPLICATION REQUIREMENTS FOR BIOSIMILAR PRODUCTS IN SAUDI ARABIA & SINGAPORE

JOSHI, SUHAS SHANKAR and V., BALAMURALIDHARA and V., CHANDAN B. (2021) MARKET AUTHORIZATION APPLICATION REQUIREMENTS FOR BIOSIMILAR PRODUCTS IN SAUDI ARABIA & SINGAPORE. Journal of International Research in Medical and Pharmaceutical Sciences, 16 (3). pp. 40-54.

Full text not available from this repository.

Abstract

Saudi Arabia goes under the centre east nations where the endorsement of biosimilar items gives certain guidelines and endorsement pathway is talked about, Saudi Food and Drug Authority (SFDA) in Saudi Arabia. It assumes a critical part in guaranteeing security, quality and openness of human, veterinary medications, beautifiers and organic items. The rule refers to about guidelines for biosimilar items and different expenses for endorsement of the items. Singapore is arranged in eastern part, which is considered as one of Asian Countries. The method of accommodation is totally extraordinary contrasted with other country. Health science Authority (HSA) is a legal board under the Ministry of Health of the Singapore Government. It is pertinent to clinical, drug and logical ability to secure and propel general wellbeing and security. In this article the administrative rules of Saudi Arabia and Singapore is talked about and looked at the MAA prerequisites in Saudi Arabia and Singapore.

Item Type: Article
Subjects: Institute Archives > Medical Science
Depositing User: Managing Editor
Date Deposited: 18 Nov 2023 03:46
Last Modified: 18 Nov 2023 03:46
URI: http://eprint.subtopublish.com/id/eprint/3656

Actions (login required)

View Item
View Item